Anthracycline rechallenge using pegylated liposomal doxorubicin in patients with metastatic breast cancer: a pooled analysis using individual data from four prospective trials

por Al-Batran, S-E, Güntner, M, Pauligk, C, Scholz, M, Chen, R, Beiss, B, Stopatschinskaja, S, Lerbs, W, Harbeck, N, Jäger, E
Publicado 2010

The clinical benefit of pegylated liposomal doxorubicin in patients with metastatic breast cancer previously treated with conventional anthracyclines: a multicentre phase II trial

por Al-Batran, S-E, Bischoff, J, von Minckwitz, G, Atmaca, A, Kleeberg, U, Meuthen, I, Morack, G, Lerbs, W, Hecker, D, Sehouli, J, Knuth, A, Jager, E
Publicado 2006